3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma.

3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma.
复制标题

早期 T 期鼻咽癌外照射放疗后 3D 图像引导 HDR 近距离放射治疗与 2D HDR 近距离放射治疗的比较

DOI:
10.1186/1471-2407-14-894
复制
发表时间:
2014-11-29
期刊:
影响因子:
3.8
通讯作者:
Wen B
Wen B
中科院分区:
医学2区
文献类型:
--
作者:
Ren Y;Zhao Q;Liu H;Huang Y;Wang Z;Cao X;Teh BS;Wen B

文献摘要

参考文献

被引文献

相似文献

背景:二维高剂量率近距离放射治疗(2D-HDR-BT)是早期T期鼻咽癌局部控制的有效剂量递增方法。尚未在早期T期NPC患者中检查外部射束放疗(ERT)后3D图像引导高剂量率近距离放射治疗(3D图像引导HDR BT)的治疗结局。目前的研究旨在评估是否添加3D-HDR-BT的ERT显示进一步改善治疗结果的早期T期鼻咽癌患者相比,2D-HDR-BT后ERT.Methods:目前的研究回顾性分析和比较治疗结果与2D-HDR-BT(n =101)或3D-HDR-BT(n =118)后ERT的非转移性T1-2b期鼻咽癌患者。两组患者均接受ERT治疗,平均剂量为60戈伊,近距离放射治疗剂量为12戈伊(8 ~ 20戈伊),2.5 ~ 5戈伊/次,局部麻醉下。结果:与ERT后接受2D-HDR-BT治疗的患者相比,ERT后接受3D-HDR-BT治疗的患者在5年精算局部控制生存率(p = 0.024)、局部/区域无复发生存率(p = 0.038)和无病生存率(p = 0.021)方面均有改善。多变量分析显示,接受3D-HDR-BT治疗的NPC患者改善了局部控制生存率(p = 0.042)。两组急性或慢性并发症的发生率相似。结论:目前的研究表明,3D图像引导下的HDR-BT后ERT是一种有效的治疗模式,T1-2期鼻咽癌患者的并发症可接受。局部肿瘤控制和无病生存率的改善可能是由于适形剂量分布的改善。
Background:Two-dimensional high-dose-rate brachytherapy (2D-HDR-BT) is an effective method of dose escalation for local tumor control in early T-stage nasopharyngeal carcinoma (NPC). Treatment outcomes for 3D-image-guided high-dose-rate brachytherapy (3D-image-guided-HDR-BT) after external beam radiotherapy (ERT) have not been examined in early T-stage NPC patients. The current study was designed to evaluate whether addition of 3D-HDR-BT to ERT showed further improvement in treatment outcomes in patients with early T-stage NPC when compared to 2D-HDR-BT after ERT.Methods:The current study retrospectively analyzed and compared treatment outcomes for patients with nonmetastatic stage T1-2b NPC treated with 2D-HDR-BT (n =101) or 3D-HDR-BT (n =118) after ERT. Patients in both groups were treated with ERT at a mean dose of 60 Gy and a brachytherapy dose of 12Gy (8 ~ 20Gy), 2.5 ~ 5Gy per fraction under local anesthesia.Results:Compared to patients treated with 2D-HDR-BT after ERT, patients treated with 3D-HDR-BT after ERT showed improvement in five-year actuarial local control survival rates (p = 0.024), local/regional relapse-free survival rates (p = 0.038), and disease-free survival rates (p = 0.021). Multivariate analysis showed that NPC patients treated with 3D-HDR-BT had improved local control survival (p = 0.042). The incidence rates of acute or chronic complications were similar between two groups.Conclusions:The current study showed that 3D-image-guided HDR-BT after ERT was an effective treatment modality for patients with stage T1-2 NPC with acceptable complications. The improvement in local tumor control and disease free survival is likely due to improved conformal dose distributions.
DOI: 10.1016/j.brachy.2012.06.001
发表时间: 2013-01-01
期刊: BRACHYTHERAPY
影响因子: 1.9
作者:
Levendag, Peter C.;Keskin-Cambay, Fatma;Teguh, David N.
通讯作者: Teguh, David N.
DOI: 10.1016/j.rpor.2014.04.013
发表时间: 2014-11-01
影响因子: 1.2
作者:
Osewski, Wojciech;Dolla, Lukasz;Slosarek, Krzysztof
通讯作者: Slosarek, Krzysztof
DOI: 10.1016/s1470-2045(11)70320-5
发表时间: 2012-02-01
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
Chen, Lei;Hu, Chao-Su;Ma, Jun
通讯作者: Ma, Jun
DOI: 10.1038/bjc.1977.1
发表时间: 1977-01
影响因子: 8.8
作者:
Peto R;Pike MC;Armitage P;Breslow NE;Cox DR;Howard SV;Mantel N;McPherson K;Peto J;Smith PG
通讯作者: Smith PG